PLEASANTON, Calif., Oct. 22 /PRNewswire-FirstCall/ — Thoratec
Corporation (Nasdaq:
THOR), a world leader in device-based mechanical circulatory
support therapies to save, support and restore failing hearts,
today announced that it will report its operating results for the
third quarter and first nine months of fiscal 2010 on Thursday,
October 28.
The company will hold a conference call to discuss its financial
results and operating activities open to all interested parties at
1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight
Time), Thursday, October 28, hosted by Gary F. Burbach, president
and chief executive officer, and David V. Smith, executive vice
president and chief financial officer.
The teleconference can be accessed by calling (719) 325-4908,
passcode 2416731. Please dial in 10-15 minutes prior the beginning
of the call. The webcast will be available on the Internet at
http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=3406099
or at http://www.thoratec.com.
A replay of the conference call will be available through
Thursday, November 4, via http://www.thoratec.com, or by
telephone at (719) 457-0820, passcode 2416731.
Thoratec is a world leader in therapies to address
advanced-stage heart failure. The company’s products include the
HeartMate® LVAS (Left Ventricular Assist System) and
Thoratec® VAD (Ventricular Assist Device) with more than 15,000
devices implanted in patients suffering from heart failure.
Additionally, its International Technidyne Corporation (ITC)
Division is a leader in point-of-care blood testing and skin
incision products. Thoratec is headquartered in Pleasanton,
California. For more info
‘/>”/>
SOURCE
